Nutritional status and antiprotease therapy.
Delforge
M L
ML
Farine
S
S
Liesnard
C
C
Gulbis
B
B
De Maertelaer
V
V
Clumeck
N
N
Farber
C M
CM
Van Vooren
J P
JP
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D015992:Body Mass Index; D015331:Cohort Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000503:physiopathology; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D019469:Indinavir / Q000494:pharmacology / Q000627:therapeutic use; D009752:Nutritional Status / Q000187:drug effects*; D010349:Patient Compliance; D011446:Prospective Studies; D019438:Ritonavir / Q000494:pharmacology / Q000627:therapeutic use; D012709:Serum Albumin / Q000032:analysis; D019562:Viral Load; D015430:Weight Gain
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D012709:Serum Albumin; D019469:Indinavir; D019438:Ritonavir